PM Philip Morris International Inc.
Cigarettes · NYSE · SEC CIK 1413329 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.9%
TTM net income YoY24.1%
TTM EPS YoY24.1%
Revenue 3-yr CAGR8.0%
Net income 3-yr CAGR10.1%
Margins
Gross margin67.7%
Operating margin38.6%
Net margin24.8%
FCF margin31.5%
EBITDA margin43.4%
Returns
ROE—
ROA16.0%
ROIC (approx.)45.1%
Asset turnover0.64x
Leverage & solvency
Liabilities / assets108.9%
Debt / equity—
Current ratio1.02x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.42x
Accruals ratio-6.6%
Payout ratio85.9%
Capex / revenue3.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $40.65B | $37.88B |
| Cost of revenue | $13.37B | $13.33B |
| Gross profit | $27.28B | $24.55B |
| R&D expense | $756.00M | $759.00M |
| Operating income | $14.89B | $13.40B |
| Interest expense | $1.59B | $1.76B |
| Pretax income | $13.88B | $12.20B |
| Income tax | $2.74B | $3.02B |
| Net income | $11.35B | $7.06B |
| EBITDA | $16.89B | $15.19B |
| EPS (basic) | 7.27 | 4.53 |
| EPS (diluted) | 7.26 | 4.52 |
| Dividends declared per share | 5.64 | 5.30 |
| Weighted avg. shares (diluted) | 1.56B | 1.56B |
| Balance sheet | ||
| Cash & equivalents | $4.87B | $4.25B |
| Receivables | $4.57B | $3.79B |
| Inventory | $11.48B | $9.45B |
| Current assets | $24.36B | $20.17B |
| PP&E, net | $8.40B | $7.31B |
| Goodwill | $17.26B | $16.60B |
| Intangibles | $10.88B | $11.33B |
| Total assets | $69.19B | $61.78B |
| Current liabilities | $25.43B | $22.91B |
| Short-term debt | $168.00M | $137.00M |
| Long-term debt | $45.13B | $42.17B |
| Total debt | $45.30B | $42.30B |
| Total liabilities | $77.21B | $71.65B |
| Shareholders' equity | -$9.99B | -$11.75B |
| Net debt | $40.43B | $38.05B |
| Cash flow statement | ||
| Operating cash flow | $12.23B | $12.22B |
| Capital expenditure | $1.57B | $1.44B |
| Free cash flow | $10.66B | $10.77B |
| Investing cash flow | -$3.97B | -$1.09B |
| Financing cash flow | -$8.13B | -$9.48B |
| Depreciation & amortization | $2.00B | $1.79B |
| Dividends paid | $8.62B | $8.20B |
| Share buybacks | — | $0 |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.